Updates

Sanders: Drug costs are out of control

Oct 1, 2015

Across the country, Americans are finding the prices of the prescription drugs… Read More

Drug firms need to explain the prices

Sep 29, 2015

Drug makers do not really want to explain how medicines are priced and, as a result, they have adopted an air of secrecy in which one cowboy can create havoc for an entire industry. Read More

Presidential Candidates Address Soaring Prescription Drug Costs

Sep 23, 2015

As the 2016 presidential race heats up, prominent candidates are beginning to unveil comprehensive plans to address soaring prescription drug costs and the harmful impact their price tags have on Americans. Read More

NYT: A Huge Overnight Increase in a Drug’s Price Raises Protests

Sep 20, 2015

Specialists in infectious disease are protesting a gigantic overnight increase in the price of a 62-year-old drug that is the standard of care for treating a life-threatening parasitic infection. Read More

Report: Prescription Drug Spending Tops Year-over-Year Price Growth for Selected Health Categories

Sep 15, 2015

"This latest health care price growth report indicates that spending on pricey prescription medications shows no sign of slowing down. When compared to other health care services, it is clear that high cost treatments continue to top the charts as a serious threat to the sustainability of our health care system and beyond." Read More

The Price for Lowering Cholesterol

Sep 9, 2015

The hepatitis C drugs, which cured a vast majority of patients in clinical trials, are essentially a one-time cost. The cholesterol drugs, by contrast, will be taken for a lifetime. At these rates, the lifetime costs could be staggering. Read More

New Cholesterol Drugs Are Vastly Overpriced, Analysis Says

Sep 9, 2015

Two powerful new drugs that can sharply lower cholesterol are vastly overpriced based on the value they provide, according to a new analysis by an independent organization that evaluates pharmaceutical costs. Read More

New effective medicines are of no use if they are unaffordable

Sep 9, 2015

The pharmaceutical industry have, in recent years, focused on development of so-called specialty drugs and have priced them aggressively. These prices, such as the US$1,000 per pill price for the hepatitis C drug sofosbuvir, are alarming for patients, employers, insurers, and governments. Read More

Insurers begin to review coverage of costly cholesterol drugs

Aug 28, 2015

“With several game-changing medications in the pipeline, we need to address the underlying issue of how these prices are set from the start before they hit the market,” John Rother, leader of the Campaign for Sustainable Rx Pricing, said in a statement. Read More

FDA Approves New Cholesterol-Lowering Treatments

Aug 28, 2015

"The approval of Repatha is another example of a breakthrough medication with a too high price tag. With several game-changing medications in the pipeline, we need to address the underlying issue of how these prices are set from the start before they hit the market.” Read More

Prescription Drug Pricing: Give the People What They Want

Aug 25, 2015

Our effort—the Campaign for Sustainable Rx Prices—has been sounding the alarm for more than a year that pharmaceutical companies must come to the table with meaningful solutions to the challenge of rising drug costs. Otherwise, companies risk the rising tide of consumer anger resulting in solutions that are not constructive for anyone. Read More

New KFF Poll: Unsustainable drug pricing moves ahead of ACA as GOP voters’ top health care concern

Aug 20, 2015

PRESS STATEMENT For Immediate Release August 20, 2015 Contact: John Rother… Read More